Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

A U.S. federal court has officially ordered Philips to restrict the production and sale of its CPAP and BiPAP ventilators for sleep apnea. The move is the culmination of a years-long international ...